UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024234
Receipt number R000027907
Scientific Title Nocturia QOL evaluation in OAB patients treated with Oxybutinin & Mirabegron study
Date of disclosure of the study information 2016/10/01
Last modified on 2023/10/17 18:49:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Nocturia QOL evaluation in OAB patients treated with Oxybutinin & Mirabegron study

Acronym

NEOXY study

Scientific Title

Nocturia QOL evaluation in OAB patients treated with Oxybutinin & Mirabegron study

Scientific Title:Acronym

NEOXY study

Region

Japan


Condition

Condition

overactive bladder

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The effect of oxybutynin tape for nocturia and sleep quality is evaluated in overactive bladder patients with nocturia, setting as a reference selective beta-3 adrenergic receptor agonist Mirabegron.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

N-QOL score

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Arm of oxybutynin tape 73.5mg per one day for 8 weeks.

Interventions/Control_2

Arm of mirabegron 50mg per one day for 8 weeks.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

20 years of age or older of overactive bladder female patients with nocturia symptoms.

Key exclusion criteria

(1) Patients in the study drug administration proposed site with a skin disease and skin abnormalities.
(2) Patients with residual urine volume greater than 100mL.
(3) Patients with a difficulty in going to the bathroom without the assistance.
(4) Patients with a history of hypersensitivity of Oxybutynin hydrochloride or Mirabegron.
(5) Patients receiving flecainide acetate or propafenone hydrochloride.
(6) Patients with severe blood, liver, kidney disease and severe arrhythmia, suffering from cardiovascular diseases such as congestive heart failure.
(7) Patients with hypokalemia (less than 3.5mEq / L).
(8) Patients with paralytic ileus, ulcerative colitis, stomach atony, patients suffering from gastrointestinal diseases, such as bowel atony.
(9) Patients with Parkinson's syndrome, dementia, suffering from psychiatric and neurological disorders or cerebrovascular disorders such as myasthenia gravis.
(10) Patients with a glaucoma.
(11) Patients with a hyperthyroidism.
(12) Patients with malignant tumors.
(13) Pregnant patients, patients in lactating, and patients want to become pregnant during test period.
(14) Patients who participated in the other interventions tested within 16 weeks prior to study drug administration.
(15) Other, patient that investigators or test sharing doctor was ineligible as a subject of the present study.

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Osamu Ishizuka

Organization

Department of Urology, school of medicine, Shinshu university

Division name

Urology

Zip code


Address

3-1-1 Asahi, Matsumoto, Nagano, Japan

TEL

+81263-35-4600

Email

yokoso1046@shinshu-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Toshiro Suzuki

Organization

Department of Urology, school of medicine, Shinshu university

Division name

Urology

Zip code


Address

3-1-1 Asahi, Matsumoto, Nagano, Japan

TEL

+81263-35-4600

Homepage URL


Email

yokoso1046@shinshu-u.ac.jp


Sponsor or person

Institute

Department of Urology, school of medicine, Shinshu university

Institute

Department

Personal name



Funding Source

Organization

Hisamitsu Pharmaceutical Co.,Inc

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 09 Month 05 Day

Date of IRB

2016 Year 09 Month 05 Day

Anticipated trial start date

2016 Year 10 Month 03 Day

Last follow-up date

2017 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded

2018 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 09 Month 30 Day

Last modified on

2023 Year 10 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027907


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name